Antiplatelet Management for Stent-Assisted Coiling and Flow Diversion of Ruptured Intracranial Aneurysms: A DELPHI Consensus Statement
- PMID: 32943417
- PMCID: PMC7661082
- DOI: 10.3174/ajnr.A6814
Antiplatelet Management for Stent-Assisted Coiling and Flow Diversion of Ruptured Intracranial Aneurysms: A DELPHI Consensus Statement
Erratum in
-
Erratum.AJNR Am J Neuroradiol. 2021 Oct;42(10):E76. doi: 10.3174/ajnr.A7238. Epub 2021 Aug 5. AJNR Am J Neuroradiol. 2021. PMID: 34353784 Free PMC article. No abstract available.
Abstract
Background and purpose: There is a paucity of data regarding antiplatelet management strategies in the setting of stent-assisted coiling/flow diversion for ruptured intracranial aneurysms. This study aimed to identify current challenges in antiplatelet management during stent-assisted coiling/flow diversion for ruptured intracranial aneurysms and to outline possible antiplatelet management strategies.
Materials and methods: The modified DELPHI approach with an on-line questionnaire was sent in several iterations to an international, multidisciplinary panel of 15 neurointerventionalists. The first round consisted of open-ended questions, followed by closed-ended questions in the subsequent rounds. Responses were analyzed in an anonymous fashion and summarized in the final manuscript draft. The statement received endorsement from the World Federation of Interventional and Therapeutic Neuroradiology, the Japanese Society for Neuroendovascular Therapy, and the Chinese Neurosurgical Society.
Results: Data were collected from December 9, 2019, to March 13, 2020. Panel members achieved consensus that platelet function testing may not be necessary and that antiplatelet management for stent-assisted coiling and flow diversion of ruptured intracranial aneurysms can follow the same principles. Preprocedural placement of a ventricular drain was thought to be beneficial in cases with a high risk of hydrocephalus. A periprocedural dual, intravenous, antiplatelet regimen with aspirin and a glycoprotein IIb/IIIa inhibitor was preferred as a standard approach. The panel agreed that intravenous medication can be converted to oral aspirin and an oral P2Y12 inhibitor within 24 hours after the procedure.
Conclusions: More and better data on antiplatelet management of patients with ruptured intracranial aneurysms undergoing stent-assisted coiling or flow diversion are urgently needed. Panel members in this DELPHI consensus study preferred a periprocedural dual-antiplatelet regimen with aspirin and a glycoprotein IIb/IIIa inhibitor.
© 2020 by American Journal of Neuroradiology.
Figures
Similar articles
-
Considerations for Antiplatelet Management of Carotid Stenting in the Setting of Mechanical Thrombectomy: A Delphi Consensus Statement.AJNR Am J Neuroradiol. 2020 Dec;41(12):2274-2279. doi: 10.3174/ajnr.A6888. Epub 2020 Oct 29. AJNR Am J Neuroradiol. 2020. PMID: 33122218 Free PMC article.
-
Safety and Efficacy of Intravenous Tirofiban as Antiplatelet Premedication for Stent-Assisted Coiling in Acutely Ruptured Intracranial Aneurysms.AJNR Am J Neuroradiol. 2016 Mar;37(3):508-14. doi: 10.3174/ajnr.A4551. Epub 2015 Oct 15. AJNR Am J Neuroradiol. 2016. PMID: 26471748 Free PMC article.
-
Complications in Stent-Assisted Endovascular Therapy of Ruptured Intracranial Aneurysms and Relevance to Antiplatelet Administration: A Systematic Review.AJNR Am J Neuroradiol. 2015 Sep;36(9):1682-8. doi: 10.3174/ajnr.A4365. Epub 2015 Jul 2. AJNR Am J Neuroradiol. 2015. PMID: 26138136 Free PMC article.
-
Safety and efficacy of a new prophylactic tirofiban protocol without oral intraoperative antiplatelet therapy for endovascular treatment of ruptured intracranial aneurysms.J Neurointerv Surg. 2016 Nov;8(11):1148-1153. doi: 10.1136/neurintsurg-2015-012055. Epub 2015 Nov 27. J Neurointerv Surg. 2016. PMID: 26614492
-
Antiplatelet Therapy in Flow Diversion.Neurosurgery. 2020 Jan 1;86(Suppl 1):S47-S52. doi: 10.1093/neuros/nyz391. Neurosurgery. 2020. PMID: 31838537 Review.
Cited by
-
Trends in Dual Antiplatelet Therapy Use for Neurointerventional Procedures for the Management of Intracranial Aneurysms.Biomedicines. 2023 Aug 9;11(8):2234. doi: 10.3390/biomedicines11082234. Biomedicines. 2023. PMID: 37626730 Free PMC article. Review.
-
What is a Challenging Clot? : A DELPHI Consensus Statement from the CLOTS 7.0 Summit.Clin Neuroradiol. 2023 Dec;33(4):1007-1016. doi: 10.1007/s00062-023-01301-2. Epub 2023 Jun 7. Clin Neuroradiol. 2023. PMID: 37284876
-
Comparison of antithrombogenic coated and uncoated flow diverters in ruptured and unruptured cerebral aneurysms.J Neuroimaging. 2025 Jan-Feb;35(1):e13253. doi: 10.1111/jon.13253. J Neuroimaging. 2025. PMID: 39636089 Free PMC article.
-
Pipeline embolization device for aneurysm recurrence after stent-assisted coiling.Neuroradiology. 2025 Feb;67(2):415-421. doi: 10.1007/s00234-024-03541-6. Epub 2025 Jan 20. Neuroradiology. 2025. PMID: 39831959
-
Neqstent coil-assisted flow diverter (NQS) for the treatment of bifurcation aneurysms: the coil-assisted flow diversion safety and performance study (CAFI).J Neurointerv Surg. 2024 Jun 17;16(7):721-725. doi: 10.1136/jnis-2022-020056. J Neurointerv Surg. 2024. PMID: 37419693 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical